← Evidence map

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2015

Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain.

G Villa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2015
2016
2017
2018
2019
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24981588